Cidara Therapeutics
Hanmari Vosloo is an experienced finance professional currently serving as Associate Director of SEC Reporting at Cidara Therapeutics since April 2020. Previously, Hanmari held positions as Senior Manager and SEC Reporting Manager within the same company. Prior to joining Cidara Therapeutics, Hanmari worked as a Consultant in a self-employed capacity from November 2018 to April 2020. Earlier in the career, Hanmari gained significant experience at Deloitte, where roles included Audit & Assurance In-Charge and Audit Senior from January 2009 to November 2018. Hanmari holds a Bachelor of Commerce degree in Chartered Accountancy from North West University Potchefstroom, earned from 2004 to 2008.
This person is not in the org chart
This person is not in any teams
Cidara Therapeutics
1 followers
Cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies.